Phase I-IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours.
European journal of cancer (Oxford, England : 1990).
Times cited: 10
- Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. The Lancet Oncology. 2011 Report GET IT
- In reply . Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Information Resource GET IT
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 268
- Phase I study of green tea extract in patients with advanced lung cancer. Cancer chemotherapy and pharmacology. 2005 Academic Article GET IT
The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease.
Times cited: 17
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 3